KA
PRTA icon

Kerrisdale Advisers’s Prothena Corp PRTA Stock Holding History

Kerrisdale Advisers’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-61,640
Closed -$483K – 36
2019
Q3 		$483K Hold
61,640
– – 0.3% 30
2019
Q2 		$652K Hold
61,640
– – 0.23% 27
2019
Q1 		$748K Buy
+61,640
New +$770K 0.14% 27

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Kerrisdale Advisers's PRTA Position: Q4 2019 in Review

Kerrisdale Advisers sold out of Prothena Corp (PRTA) in Q4 2019, closing a stake of 61,640 shares — an estimated $483K sold.

Kerrisdale Advisers first reported a position in PRTA in Q1 2019 and held it in 3 quarters. The position peaked at $748K in Q1 2019. 141 funds tracked by Wall St. Rank hold PRTA as of Q4 2019.

  • Kerrisdale Advisers reported no remaining Prothena Corp position as of Q4 2019 after selling out during the quarter.
  • Kerrisdale Advisers sold 61,640 Prothena Corp shares in Q4 2019, an estimated $483K.
  • Kerrisdale Advisers first reported a position in Prothena Corp in Q1 2019 and held it in 3 quarters.
  • Kerrisdale Advisers's Prothena Corp position peaked at $748K in Q1 2019.
  • 141 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2019.

Based on Kerrisdale Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.